Mignar25-MF Tablet SR
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Metformin (500mg) + Miglitol (25mg)
Overview Mignar25-MF Tablet SR
Diabex Duo 25-MF Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It aids in regulating blood glucose levels. Diabex Duo 25-MF ER should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar or feeling well. Discontinuing treatment without medical consultation can lead to elevated blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are vital in diabetes control. Potential side effects include nausea, altered taste perception, decreased appetite, gas, abdominal discomfort, diarrhea, and skin reactions. These are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your doctor can offer management strategies or treatment for bothersome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment, as it may be unsuitable. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Mignar25-MF Tablet SR
Managing type 2 diabetes
Major Benefits of Mignar25-MF Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mignar25-MF Tablet SR should be administered with a meal.
Common Side effects of Mignar25-MF Tablet SR:
- Nausea
- Loss of appetite
- Taste change
- Stomach pain
- Flatulence
- Diarrhea
- Skin rash
How to use Mignar25-MF Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mignar25-MF Tablet SR with a meal.
How Mignar25-MF Tablet SR works:
Mignar25-MF sustained-release tablets contain a dual antidiabetic drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mignar25-MF Tablet SR and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
Use of Mignar25-MF Tablet SR during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Extended-release Mignar25-MF tablets are likely safe for breastfeeding mothers. Available human data indicate minimal infant risk associated with the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Mignar25-MF Tablet SR to individuals with impaired renal function; dosage modification might be necessary. Consult a physician before administering. Mignar25-MF Tablet SR is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Mignar25-MF Tablet SR in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Mignar25-MF Tablet SR :
NA
Facts to Know About Mignar25-MF Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently